Informační systém MU
KOLÁŘ, Milan, Iva VÁGNEROVÁ, Roman PANTŮČEK a P. ČERMÁK. Impact of rational antibiotic usage on occurrence of vancomycin-resistant enterococci in hematological patients. Clinical Microbiology and Infection. Oxford: Blackwell Science, 2001, roč. 7, Suppl 1, s. 91. ISSN 1469-0691.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Impact of rational antibiotic usage on occurrence of vancomycin-resistant enterococci in hematological patients
Autoři KOLÁŘ, Milan (203 Česká republika), Iva VÁGNEROVÁ (203 Česká republika), Roman PANTŮČEK (203 Česká republika) a P. ČERMÁK (203 Česká republika).
Vydání Clinical Microbiology and Infection, Oxford, Blackwell Science, 2001, 1469-0691.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10600 1.6 Biological sciences
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW [Abstract] [Full Text]
Kód RIV RIV/00216224:14310/01:00004694
Organizační jednotka Přírodovědecká fakulta
Změnil Změnil: prof. RNDr. Roman Pantůček, Ph.D., učo 842. Změněno: 18. 9. 2005 17:38.
Anotace
Objectives: The hematological patients are jeopardised by staphylococci and enterococci from the group of Gram-positive bacteria. Especially great danger for the hematological patients are the vancomycin-resistant enterococci that may be a very big therapeutic problem in some cases. Methods: Enterococci were isolated from clinical samples of patients hospitalised at the Department of Hemato-oncology of University Hospital in Olomouc, Czech Republic, during period 1995-2000. The usage of antibiotics was expressed as the number of defined daily doses (DDD) per 1000 bed-days (RDDD) during the observation periods according to the following formula: RDDD=DDD x 1000/NB (NB=number of bed-days). To evaluate the selection pressure of antibiotics and occurrence of VRE, we used each six-month interval from 1st half of 1997 to 1st half of 2000. Results: In total, 1918 strains were isolated in the Department of Hemato-oncology, from which 138 (7.2%) were identified as VRE. The percentage of VRE in the mentioned department was within the interval 1.7-15.1%. The highest occurrence (15.1%) was detected in the second half of 1998. In the following periods, the number of VRE gradually decreased to the value of 6.1% in the first half of 2000. The application of glycopeptides has decreased by 68.2% after evaluating the period of 1997-2000. A distinct decline is accomplished especially in vancomycin. A distinct decline (by 75.3%) is achieved in the case of IIIrd generation cephalosporins as well. The selection pressure of fluoroquinolones was not reduced until 1999, when the usage of these antimicrobial preparations decreased by 47.3% compared to 1997 and compared to 1998 by 46.4%. Conclusion: Based on the comparison of the selection pressure progress of antibiotics and the percentage of VRE in each period of observation, we can assume the influence of the application of each antibiotic group on the occurrence of VRE. A distinct decline of the application of third-generation cephalosporins, glycopeptides and fluoroquinolones and its replacement with penicillin antibiotics combined with inhibitors of bacterial beta-lactamases (amoxicillin/clavulanic acid, ampicillin/sulbactam, piperacillin/tazobactam), had a great influence on the cessation of the increasing occurrence of VRE and a following decline of its occurrence from 15.1% in the second half of 1998 to 6.1% in the first half of 2000.
Návaznosti
GA301/99/D075, projekt VaVNázev: Genotypová diagnostika a typizace klinicky významných koaguláza negativních stafylokoků
Investor: Grantová agentura ČR, Genotypová diagnostika a typizace klinicky významných koaguláza negativních stafylokoků
MSM 143100008, záměrNázev: Genomy a jejich funkce
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Genomy a jejich funkce
Zobrazeno: 30. 4. 2024 11:45